News Headline Summary

Celgene (CELG) gets Apremilast orphan status for Behect's disease

Reaction details:

- Small move to the upside following this news, last trade at USD 99.01 (+0.15%).

Print 18:03, 17 Jan 2013 - US Equities - Source: Hammerstone